Connection
Myron Levin to Antibodies, Protozoan
This is a "connection" page, showing publications Myron Levin has written about Antibodies, Protozoan.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.114 |
|
|
|
-
Labovsky V, Smulski CR, Gómez K, Levy G, Levin MJ. Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. Clin Exp Immunol. 2007 Jun; 148(3):440-9.
Score: 0.255
-
Smulski C, Labovsky V, Levy G, Hontebeyrie M, Hoebeke J, Levin MJ. Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptor. FASEB J. 2006 Jul; 20(9):1396-406.
Score: 0.242
-
Lopez Bergami P, Gómez KA, Levy GV, Grippo V, Baldi A, Levin MJ. The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition. Clin Exp Immunol. 2005 Oct; 142(1):140-7.
Score: 0.230
-
Mahler E, Hoebeke J, Levin MJ. Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease. Clin Exp Immunol. 2004 Jun; 136(3):527-34.
Score: 0.210
-
López Bergami P, Scaglione J, Levin MJ. Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J. 2001 Dec; 15(14):2602-12.
Score: 0.176